Discover the revival of the biotech sector, with IPOs resurging and promising weight loss drug potential, despite facing ...

The U.S. IPO market looks to be gathering steam, with a few names springing up that are attracting investor attention.

Among the investors in Aktis’ Series B round were Bristol Myers Squibb, Eli Lilly and Merck & Co., all of which have expanded their involvement in the radiopharma field.

The Fed's dovish pivot and rate cuts, combined with strong employment, signal a low recession risk and potential economic ...

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on BridgeBio Pharma (BBIO – Research Report) today and set a price target ...

The Ministry of Education is trying to adapt, on the fly, to the reality on the ground. The didactic activity with physical ...

Piper Sandler analyst Biren Amin maintained a Buy rating on BridgeBio Pharma (BBIO – Research Report) today and set a price target of $46.00. The company’s shares closed last Friday at $24.94.

The man charged with attempting to assassinate Donald Trump after allegedly positioning himself with a rifle outside one of the former president’s Florida golf courses is due to appear in court ...

Uttar Pradesh CM Yogi Adityanath highlighted the BJP's achievements in Haryana during a public meeting in Bhiwani, focusing on improved connectivity and new institutions. He criticized Congress ...

Get the latest Australian and world news covering breaking news and trending topics that educate, engage and entertain. Learn more about where you live, the language you speak, and how the country ...

Their stories come as the county is undergoing a public reckoning over child welfare policies ...